A new study conducted by researchers at the University of Albany found that patients, who were hospitalized in the New York area, did not benefit from hydroxychloroquine.

Hydroxychloroquine is the anti-malaria drug which the US president, Donald Trump, repeatedly praised as a possible treatment for the coronavirus. In March, US authorities issued an emergency use authorization to let medical workers use the drug on certain COVID-19 patients.

Researchers looked at more than 1,400 COVID-19 patients, and they found that the patients, who received hydroxychloroquine, did not get better or worse than the patients who did not receive it. The study is not considered conclusive because it did not fulfill all necessary criteria. The state of New York is currently conducting a randomized controlled trial on the drug.

Difficult words: conclusive (proving that something is true), criteria (rules or principles that are used for evaluating or testing something), randomized controlled trial (a study that chooses participants randomly).